Arcutis Biotherapeutics Stock (ARQT)

Track Arcutis Biotherapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.

$23.93

▲ +4.16 (+21.05%) past year

Live · Updated Oct 7, 9:36 AM ET

Market Cap

$3.16B

P/E Ratio

108.3x

1Y Return

+21.05%

EPS (TTM)

$0.21

Read the latest TheStreet Pro articles mentioning Arcutis Biotherapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.

Articles

3 articles

trade-ideas Growth Stocks Exist Outside of Tech. I'm Eyeing Two of Them Right Now
Bret JensenApr 27, 2026
ARQT JD INTC
trade-ideas Amid Volatility, These Two Biotechs Steadily Strengthen
Bret JensenNov 21, 2025
ARQT NVDA NUVB
trade-ideas Key Ratios Indicate: Speculators Might Be Feeling Comfortable Again
Helene MeislerOct 15, 2025
ARQT VZ MDB

Daily Diary Mentions

0 mentions

No diary mentions for ARQT yet.